Characterisation and response of intestinal microflora and mucins to manno-oligosaccharide and antibiotic supplementation in broiler chickens.
1. An experiment was conducted to characterise and evaluate, in comparison to zinc bacitracin (ZnB), the response of intestinal microflora and mucins to manno-oligosacchares (MOS, Bio-MOS(R), Alltech Biotechnology, Nicholasville, Kentucky, USA). 2. Supplementation of MOS and ZnB selectively increased the intensity of sulphomucins. As revealed by the plate culture method, MOS accelerated the maturation of gut microflora by promoting the growth of lactobacilli in the ileal mucosa and vice versa on ileal and caecal clostridia. Unlike MOS, ZnB suppressed the growth of intestinal bacteria, especially those of lactobacilli and clostridia. Use of T-RFLP further revealed that MOS increased the diversity of lactobacilli in the ileum and ileal mucosa but the opposite was observed for ZnB. It also appears that MOS and ZnB possessed a common property in differentially favouring the growth of certain Lactobacillus species. There was also evidence to show that both MOS and ZnB also increased the homogeneity of the gut microflora, possibly through the regulation of the overall gut bacterial communities. 3. Improvement in intestinal microbial homogeneity and mucin synthesis, coupled with the differential selections for certain specific beneficial bacterial species, may ultimately be proven to be the target mechanisms in the search for more effective alternatives to antibiotics.
Chee
S H
SH
University of New England, Armidale, NSW, Australia.
Iji
P A
PA
Choct
M
M
Mikkelsen
L L
LL
Kocher
A
A
D000821:Animal Feed; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001414:Bacitracin / Q000494:pharmacology*; D001835:Body Weight; D002645:Chickens / Q000254:growth & development / Q000378:metabolism / Q000382:microbiology*; D003013:Clostridium / Q000187:drug effects / Q000235:genetics / Q000254:growth & development; D015169:Colony Count, Microbial; D007082:Ileum / Q000382:microbiology; D007413:Intestinal Mucosa / Q000382:microbiology; D007422:Intestines / Q000382:microbiology*; D007778:Lactobacillus / Q000187:drug effects / Q000235:genetics / Q000254:growth & development; D009077:Mucins / Q000096:biosynthesis*; D009844:Oligosaccharides / Q000494:pharmacology*; D010802:Phylogeny; D012150:Polymorphism, Restriction Fragment Length; D015430:Weight Gain
D000900:Anti-Bacterial Agents; D009077:Mucins; D009844:Oligosaccharides; D001414:Bacitracin